Menitove J E, Chambers L A, Gjertsonet D W et al. Unexpected Antibodies to Red Cell Antigens and Serologic Crossmatch. In: Gorlin J B, Clegg V, Elliott K, et al.Standards for Blood Banks and Transfusion Services, 21st edition. Bethesda, MD: American Association of Blood Banks (or AABB); 2002. p. 44-45. http://www.dsmanitoba.ca/professionals/transfusion/AABB/STANDARD/STAND21.PDF (accessed on 10th April 2013).
Hillyer CD, Shaz BH, Zimring JC, et al. Pretransfusion Testing. Transfusion Medicine and Hemostasis. Burlington MA: Elsevier, 2009.
Combs MR, Denomme G, Grossman B J, et al. Red Cell antigen-antibody reactions and their detection. In: Brecher ME, Leger RM, Linden JV, et al. Technical Manual, 15th edition. Bethesda, MD: American Association of Blood Banks (or AABB), 2005.p.276-286.http://www.dsmanitoba.ca/professionals/transfusion/AABB/CHAPTR15/chap12.pdf (accessed on 10th April 2013).
Judd WJ, Steiner EA, O'Donnell DB, Oberman HA. Discrepancies in reverse ABO typing due to prozone: How safe is the immediate-spin crossmatch? Transfusiom 1988; 28: 334-8.
Oduola T, Albi O, Adedire A, Aluko O. Low Ionic Strength Solution-Antihuman Globulin Crossmatch: A safer approach to request for uncrossmatched blood. The Internet Journal of Hematology 2006; DOI 10.5580/2605.
Pinkerton PH, Coovadia AS, Goldstein J. Frequency of delayed haemolytic transfusion reactions following antibody screening and immediate-spin crossmatching. Transfusion 1992; 32: 814-7.
Schonewille H, van de Watering L, Loomans D and Brand A. Red blood cell alloantibodies after transfusion: factor influencing incidence and specificity, Transfusion 2006, 46: 250-6.
Weisbach V, Kohnhauser T, Zimmermann R et al. Comparison of the performance of microtube column systems and solid-phase systems and the low- ionic-strength, Transfusion Medicine 2006; 16: 276-84.
Garozzo G, Licitra V, Criscione R, et al. A comparison of two automated methods for the detection and identification of red blood cell alloantibodies. Blood Transfusion 2007; 5: 33-40.
Zakariah AY, Alexander S, van Roosmalen J, et al. Reproductive age mortality survey (RAMOS) in Accra, Ghana. Reprod Health 2009; 6:7-12.
Natukunda B, Schonewille H, Smit Sibinga CT. Assessment of the clinical transfusion practice at a regional referral hospital in Uganda. Transfus Med 2010; 20: 134-139.
Kajja I, Bimenya G, Smit Sibinga C. The interface between blood preparation and use in Uganda. Vox Sang 2010; 98: e257-e262.
Natukunda B, Schonewille H, van de Watering L, Brand A. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sang 2010; 98: 167-171.
Natukunda B, Schonewille H, Ndugwa C, Brand A. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion 2010; 50: 20-25.
Baby M, Fongoro S, Cissé S, et al. Fréquence de l’allo-immunization érythrocytaire chez les malades polytransfusés au centre hospitalo-universitaire du Point G, Bamako, Mali. Transfus Clin Biol. 2010 Oct; 17: 218-22.
M’baya B, Mfune T, Mogombo E, et al. The prevalence of red cell antigens and antibodies in Malawi. Transfus Med 2010; 20: 196-199.
Meunier N, Rodet M, Bonin P, et al. Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply. Transfus Clin Biol 2008;15: 377-82.
Tournamille C, Meunier-Costes N, Costes B, et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 2010;50: 2-4.
Norol F, Nadjahi J, Bachir D, et al. Transfusion and alloimmunization in sickle cell anemia patients. Transfus Clin Biol 1994; 1: 27-34.
Bauer MP, Wiersum-Osselton J, Schipperus M, et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007; 47: 2066-71.
Schonewille H, de Vries RR, Brand A. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion 2009; 49: 453-457.
Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a non hematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006; 46: 630-635.
